FA/General Discussion, page-18

. For combating antibiotic resistance I think Febridx has massive potential.
but I read the following study regards Febridx and Covid. Cambridge state it is of limited use in settings with low prevalence.

Field clinical performance of SARS-CoV-2 point-of-care diagnostic tests: a living systematic reviewof trials up to 17th of August, 2021Gabriel Hawthorne1,2, Adam Harvey21Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom2Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden, United KingdomCorresponding address: [email protected]*m

"We found a few studies using the FebriDx device (Lumos diagnostics), which captures
Myxovirus resistance protein A (MxA - a marker of interferon-induced antiviral host response) and C
reactive protein (a well-known and widely used inflammatory marker in medical practice). In one study,
the assay had a sensitivity of 93% and a specificity of 86%162 (with an estimated prevalence of 48% in the
studied population).

As the markers are commonly elevated for a range of pathogens, the test has a low specificity and has limited use in settings with low prevalence.


This is just one opinion. I'm not in the medical field, have no real idea.